PHARMARON BEIJING CO., LTD. Funds and ETFs Pharmaron Beijing Co., Ltd.
Equities
300759
CNE100003JW4
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.16 CNY | +5.04% |
|
+5.39% | -33.89% |
| Apr. 26 | Pharmaron Beijing Posts 34% Profit Drop in Q1 as Revenue Slips 2% | MT |
| Apr. 26 | Nomura Adjusts Pharmaron Beijing Co's Price Target to HK$15.41 From HK$17.99, Keeps at Buy | MT |
ETFs positioned on Pharmaron Beijing Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.17% | 2 M€ | -16.59% | - | |
| 0.13% | 35 M€ | -5.85% | - | |
| 0.10% | 3 M€ | -0.84% | - | |
| 0.06% | 2 M€ | -.--% | ||
| 0.05% | 4 M€ | -11.56% | ||
| 0.03% | 7 M€ | -.--% | - | |
| 0.01% | 117 M€ | +1.11% | - | |
| 0.01% | 2,808 M€ | +5.90% | - | |
| 0.01% | 441 M€ | +4.60% | - | |
| 0.01% | 149 M€ | +2.17% | - | |
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 7 M€ | +1.95% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 147 M€ | +4.88% | - | |
| 0.00% | 15 M€ | +11.24% |
Pharmaron Beijing Co. is specialised in the research, development and manufacturing of small molecule drugs, cell therapies and gene therapies. Net sales break down by activity as follows:
- laboratory services (61.3%);
- development and production of chemical processes and formulations (23.5%);
- clinical research services (12.8%);
- other (2.4%);
Net sales are distributed geographically as follows: China (17.1%), Asia (2.6%), North America (64.2%), Europe (15.6%) and other (0.5%).
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
19.16
CNY
Average target price
25.3
CNY
Spread / Average Target
+32.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -33.89% | 3.94B | |
| +1.51% | 42.59B | |
| +8.57% | 40.65B | |
| +49.22% | 40.57B | |
| -12.36% | 26.77B | |
| +8.92% | 24.81B | |
| -25.13% | 18.17B | |
| +29.17% | 12.05B | |
| -3.12% | 11.7B | |
| +6.35% | 11.1B |
- Stock Market
- Equities
- 300759 Stock
- Funds and ETFs Pharmaron Beijing Co., Ltd.
